|
Global Med Technologies, Inc. - Price Analysis Snapshot
This Report features up to a ten-year record of the equity Price history for Global Med Technologies, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
Global Med Technologies, Inc.. The Group's principal activity is to design, develop, market and support information management software products for blood banks, hospitals, centralized transfusion centers and other health care related facilities. It provides blood and laboratory software systems and services and is products are deployed in 20 countries and serve over 1,600 transfusion centers, blood banks and laboratories. Its core products include: SafeTrace(R), SafeTrace Tx(R), and our ElDoradoTM product suite. SafeTrace is used to assist community blood centers, hospitals, plasma centers and outpatient clinics. SafeTrace Tx provides electronic cross-matching capabilities to help insure blood compatibility with patient-recipients and tracks, inventories, bills and documents all activities with blood products. It operates in the United States, Canada, European Union and Africa.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|